Cargando…

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy

Detalles Bibliográficos
Autores principales: An, Myeonghyun, Park, Yae Min, Seo, Jeongduk, Lee, Joonpyo, Jang, Albert Youngwoo, Kang, Woong Chol, Chung, Wook-Jin, Choi, In Suck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Cardiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541780/
https://www.ncbi.nlm.nih.gov/pubmed/37599635
http://dx.doi.org/10.14744/AnatolJCardiol.2023.3474
_version_ 1785113972154826752
author An, Myeonghyun
Park, Yae Min
Seo, Jeongduk
Lee, Joonpyo
Jang, Albert Youngwoo
Kang, Woong Chol
Chung, Wook-Jin
Choi, In Suck
author_facet An, Myeonghyun
Park, Yae Min
Seo, Jeongduk
Lee, Joonpyo
Jang, Albert Youngwoo
Kang, Woong Chol
Chung, Wook-Jin
Choi, In Suck
author_sort An, Myeonghyun
collection PubMed
description
format Online
Article
Text
id pubmed-10541780
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Turkish Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-105417802023-10-02 Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy An, Myeonghyun Park, Yae Min Seo, Jeongduk Lee, Joonpyo Jang, Albert Youngwoo Kang, Woong Chol Chung, Wook-Jin Choi, In Suck Anatol J Cardiol Case Report Turkish Society of Cardiology 2023-10-01 /pmc/articles/PMC10541780/ /pubmed/37599635 http://dx.doi.org/10.14744/AnatolJCardiol.2023.3474 Text en 2023 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Case Report
An, Myeonghyun
Park, Yae Min
Seo, Jeongduk
Lee, Joonpyo
Jang, Albert Youngwoo
Kang, Woong Chol
Chung, Wook-Jin
Choi, In Suck
Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
title Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
title_full Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
title_fullStr Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
title_full_unstemmed Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
title_short Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
title_sort thromboembolic events in patients with hypertrophic cardiomyopathy and atrial fibrillation during new oral anticoagulant therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541780/
https://www.ncbi.nlm.nih.gov/pubmed/37599635
http://dx.doi.org/10.14744/AnatolJCardiol.2023.3474
work_keys_str_mv AT anmyeonghyun thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy
AT parkyaemin thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy
AT seojeongduk thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy
AT leejoonpyo thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy
AT jangalbertyoungwoo thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy
AT kangwoongchol thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy
AT chungwookjin thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy
AT choiinsuck thromboemboliceventsinpatientswithhypertrophiccardiomyopathyandatrialfibrillationduringneworalanticoagulanttherapy